| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absent benefit of accelerated concomitant chemoradiotherapy
|
Prestwich, Robin J
|
|
2012
|
13 |
4 |
p. e136-
1 p.
|
artikel
|
| 2 |
Absent benefit of accelerated concomitant chemoradiotherapy – Authors' reply
|
Bourhis, Jean
|
|
2012
|
13 |
4 |
p. e136-e137
nvt p.
|
artikel
|
| 3 |
Anti-CD22 therapy in acute lymphoblastic leukaemia
|
Hoelzer, Dieter
|
|
2012
|
13 |
4 |
p. 329-331
3 p.
|
artikel
|
| 4 |
Aromatase inhibitors and musculoskeletal adverse events
|
Liedke, Pedro ER
|
|
2012
|
13 |
4 |
p. 333-334
2 p.
|
artikel
|
| 5 |
Aromatase inhibitors in premenopausal breast cancer
|
Kelly, Catherine M
|
|
2012
|
13 |
4 |
p. 320-321
2 p.
|
artikel
|
| 6 |
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
|
Pearce, Celeste Leigh
|
|
2012
|
13 |
4 |
p. 385-394
10 p.
|
artikel
|
| 7 |
Biology-driven medicine: tissue matters
|
The Lancet Oncology,
|
|
2012
|
13 |
4 |
p. 319-
1 p.
|
artikel
|
| 8 |
BRCA1 testing for triple-negative breast cancer
|
Bennet, Neil
|
|
2012
|
13 |
4 |
p. e143-
1 p.
|
artikel
|
| 9 |
Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial
|
Litière, Saskia
|
|
2012
|
13 |
4 |
p. 412-419
8 p.
|
artikel
|
| 10 |
Cancer drugs not approved for Australian Government subsidies
|
Kenyon, Georgina
|
|
2012
|
13 |
4 |
p. e145-
1 p.
|
artikel
|
| 11 |
Cancer risk and juvenile idiopathic arthritis
|
Astudillo, Olaya
|
|
2012
|
13 |
4 |
p. e144-
1 p.
|
artikel
|
| 12 |
Carcinogenicity of malaria and of some polyomaviruses
|
Bouvard, Véronique
|
|
2012
|
13 |
4 |
p. 339-340
2 p.
|
artikel
|
| 13 |
Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study
|
Mieog, J Sven D
|
|
2012
|
13 |
4 |
p. 420-432
13 p.
|
artikel
|
| 14 |
Cola colourant carcinogenicity claims
|
Furlow, Bryant
|
|
2012
|
13 |
4 |
p. e146-
1 p.
|
artikel
|
| 15 |
Crowding out cancer
|
Christodoulou, Mario
|
|
2012
|
13 |
4 |
p. 342-
1 p.
|
artikel
|
| 16 |
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study
|
Fleischhauer, Katharina
|
|
2012
|
13 |
4 |
p. 366-374
9 p.
|
artikel
|
| 17 |
Encouraging results for imatinib in advanced chordoma
|
Senior, Kathryn
|
|
2012
|
13 |
4 |
p. e147-
1 p.
|
artikel
|
| 18 |
End of the road for red meat?
|
Burki, Talha Khan
|
|
2012
|
13 |
4 |
p. e147-
1 p.
|
artikel
|
| 19 |
Erratum
|
|
|
2012
|
13 |
4 |
p. e134-e135
nvt p.
|
artikel
|
| 20 |
Erratum
|
|
|
2012
|
13 |
4 |
p. e135-
1 p.
|
artikel
|
| 21 |
Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?
|
van Loon, Judith
|
|
2012
|
13 |
4 |
p. e169-e177
nvt p.
|
artikel
|
| 22 |
Genetic heterogeneity and cancer drug resistance
|
Turner, Nicholas C
|
|
2012
|
13 |
4 |
p. e178-e185
nvt p.
|
artikel
|
| 23 |
Indian government awards compulsory licence for sorafenib
|
Burki, Talha Khan
|
|
2012
|
13 |
4 |
p. e146-
1 p.
|
artikel
|
| 24 |
Industry group “threatens” journals to delay publications
|
Furlow, Bryant
|
|
2012
|
13 |
4 |
p. 337-
1 p.
|
artikel
|
| 25 |
Inflammatory HER2-positive breast cancer
|
Dirix, Luc Y
|
|
2012
|
13 |
4 |
p. 324-326
3 p.
|
artikel
|
| 26 |
Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
|
Kantarjian, Hagop
|
|
2012
|
13 |
4 |
p. 403-411
9 p.
|
artikel
|
| 27 |
Link between endometriosis and ovarian-cancer subtypes
|
Gourley, Charlie
|
|
2012
|
13 |
4 |
p. 326-328
3 p.
|
artikel
|
| 28 |
Long-term outcome of breast conserving therapy
|
Benson, John R
|
|
2012
|
13 |
4 |
p. 331-333
3 p.
|
artikel
|
| 29 |
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
|
Biganzoli, Laura
|
|
2012
|
13 |
4 |
p. e148-e160
nvt p.
|
artikel
|
| 30 |
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
|
Masuda, Norikazu
|
|
2012
|
13 |
4 |
p. 345-352
8 p.
|
artikel
|
| 31 |
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study
|
Pierga, Jean-Yves
|
|
2012
|
13 |
4 |
p. 375-384
10 p.
|
artikel
|
| 32 |
Permissive mismatches for blood and marrow transplantation
|
Szabolcs, Paul
|
|
2012
|
13 |
4 |
p. 323-324
2 p.
|
artikel
|
| 33 |
Pink Ribbons, Inc
|
Burki, Talha Khan
|
|
2012
|
13 |
4 |
p. 343-
1 p.
|
artikel
|
| 34 |
Primary care and diagnosis of cancer
|
Gulliford, Martin
|
|
2012
|
13 |
4 |
p. 321-323
3 p.
|
artikel
|
| 35 |
SBRT and spinal metastasis: finding its niche
|
Schiff, David
|
|
2012
|
13 |
4 |
p. 328-329
2 p.
|
artikel
|
| 36 |
Screening of symptomatic women for ovarian cancer
|
Gentry-Maharaj, Aleksandra
|
|
2012
|
13 |
4 |
p. e138-e139
nvt p.
|
artikel
|
| 37 |
Screening of symptomatic women for ovarian cancer
|
Tone, Alicia A
|
|
2012
|
13 |
4 |
p. e137-e138
nvt p.
|
artikel
|
| 38 |
Screening of symptomatic women for ovarian cancer
|
Crum, Christopher P
|
|
2012
|
13 |
4 |
p. e137-
1 p.
|
artikel
|
| 39 |
Screening of symptomatic women for ovarian cancer – Authors' reply
|
Gilbert, Lucy
|
|
2012
|
13 |
4 |
p. e139-e140
nvt p.
|
artikel
|
| 40 |
Second-line erlotinib for non-small-cell lung cancer
|
Lorusso, Vito
|
|
2012
|
13 |
4 |
p. e141-e142
nvt p.
|
artikel
|
| 41 |
Second-line erlotinib for non-small-cell lung cancer – Authors' reply
|
Ciuleanu, Tudor
|
|
2012
|
13 |
4 |
p. e142-
1 p.
|
artikel
|
| 42 |
Semper Fi: Always Faithful
|
Burki, Talha Khan
|
|
2012
|
13 |
4 |
p. 344-
1 p.
|
artikel
|
| 43 |
Semuloparin for thromboprophylaxis during chemotherapy
|
Dehnel, Tim
|
|
2012
|
13 |
4 |
p. e143-
1 p.
|
artikel
|
| 44 |
Standardisation of clinical breast-density measurement
|
Ng, Kwan-Hoong
|
|
2012
|
13 |
4 |
p. 334-336
3 p.
|
artikel
|
| 45 |
Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial
|
Wang, Xin Shelley
|
|
2012
|
13 |
4 |
p. 395-402
8 p.
|
artikel
|
| 46 |
Study shows how NSAIDs inhibit lymphatic metastasis
|
Bennet, Neil
|
|
2012
|
13 |
4 |
p. e144-
1 p.
|
artikel
|
| 47 |
Tattoos, inks, and cancer
|
Kluger, Nicolas
|
|
2012
|
13 |
4 |
p. e161-e168
nvt p.
|
artikel
|
| 48 |
Unrest in Bulgarian health services
|
Burki, Talha Khan
|
|
2012
|
13 |
4 |
p. 338-
1 p.
|
artikel
|
| 49 |
US judge strikes down graphic tobacco warnings
|
Furlow, Bryant
|
|
2012
|
13 |
4 |
p. e145-
1 p.
|
artikel
|
| 50 |
Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England
|
Lyratzopoulos, Georgios
|
|
2012
|
13 |
4 |
p. 353-365
13 p.
|
artikel
|
| 51 |
Voices from the front: April
|
Mastrianni, David M
|
|
2012
|
13 |
4 |
p. 344-
1 p.
|
artikel
|
| 52 |
Wit
|
van Dorn, Aaron
|
|
2012
|
13 |
4 |
p. 341-
1 p.
|
artikel
|
Tijdschrift beschrijving